FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366583906> ?p ?o ?g. }

• W4366583906 endingPage "1455" @default.
• W4366583906 startingPage "1446" @default.
• W4366583906 abstract "Abstract Introduction In addition to standard highly active antiretroviral therapy protocols, complementary therapies using natural compounds are widely used by human immunodeficiency virus (HIV)‐infected human patients. One such compound is the fermented wheat germ extract (FWGE), named Avemar. Materials and methods In this study, we investigate the effects of Avemar in a feline‐acquired immunodeficiency syndrome model. MBM lymphoid cells were acutely infected by the American feline immunodeficiency virus (FIV)‐Petaluma (FIV‐Pet) and the European FIV Pisa‐M2 strains. FL‐4 lymphoid cells, continuously producing FIV‐Pet, served as a model for chronic infection. Crandell Rees feline kidney (CRFK) cells were infected by either FIV‐Pet or feline adenovirus (FeAdV) as a model for transactivation and opportunistic viral infection. Cell cultures were treated pre‐ and post‐infection with serial dilutions of spray‐dried FWGE (Avemar pulvis, AP), a standardized active ingredient in commercial Avemar products. Residual FIV and FeAdV infectivity was quantified. Results In a concentration‐dependent manner, AP inhibited replication of FIV strains in MBM and CRFK cells by 3–5 log. Low AP concentration prevented FIV‐Pet release from FL‐4 cells. Higher concentrations destroyed virus‐producing cells with cytopathic effects resembling apoptosis. AP strongly inhibited FeAdV production inside CRFK cells but not in HeLa cells. Adenovirus particles are then released via the disintegration of CRFK cells. Discussion This report is the first to describe the antiviral effects of Avemar. Further studies are required to confirm its in vitro and in vivo effects and to investigate the potential for its use as a nutraceutical in FIV‐infected felines or HIV‐infected humans. Conclusion Avemar, as a single nutraceutical, inhibits FIV replication and destroys retrovirus carrier cells. An important conclusion is that prolonged Avemar treatment might reduce the number of retrovirus‐producing cells in the host." @default.
• W4366583906 created "2023-04-23" @default.
• W4366583906 creator A5005312414 @default.
• W4366583906 creator A5011138785 @default.
• W4366583906 creator A5026533666 @default.
• W4366583906 creator A5034838757 @default.
• W4366583906 creator A5035014056 @default.
• W4366583906 creator A5040336064 @default.
• W4366583906 creator A5041613924 @default.
• W4366583906 creator A5081043336 @default.
• W4366583906 date "2023-04-20" @default.
• W4366583906 modified "2023-10-14" @default.
• W4366583906 title "The effects of Avemar treatment on feline immunodeficiency virus infected cell cultures" @default.
• W4366583906 cites W1497733922 @default.
• W4366583906 cites W1528202454 @default.
• W4366583906 cites W1950423469 @default.
• W4366583906 cites W1968804899 @default.
• W4366583906 cites W1992305356 @default.
• W4366583906 cites W1999880707 @default.
• W4366583906 cites W2000090586 @default.
• W4366583906 cites W2028321359 @default.
• W4366583906 cites W2035841130 @default.
• W4366583906 cites W2052865003 @default.
• W4366583906 cites W2055552492 @default.
• W4366583906 cites W2074283817 @default.
• W4366583906 cites W2078816486 @default.
• W4366583906 cites W2117872781 @default.
• W4366583906 cites W2118918558 @default.
• W4366583906 cites W2125539685 @default.
• W4366583906 cites W2129817567 @default.
• W4366583906 cites W2151091781 @default.
• W4366583906 cites W2151317983 @default.
• W4366583906 cites W2151512225 @default.
• W4366583906 cites W2157092295 @default.
• W4366583906 cites W2161565683 @default.
• W4366583906 cites W2165237186 @default.
• W4366583906 cites W2170329551 @default.
• W4366583906 cites W2256756668 @default.
• W4366583906 cites W2399038115 @default.
• W4366583906 cites W2746740747 @default.
• W4366583906 cites W2775297007 @default.
• W4366583906 cites W2781794320 @default.
• W4366583906 cites W2896233036 @default.
• W4366583906 cites W2954686127 @default.
• W4366583906 cites W2968692721 @default.
• W4366583906 cites W2990177956 @default.
• W4366583906 cites W3025947743 @default.
• W4366583906 cites W3080259521 @default.
• W4366583906 cites W3110003377 @default.
• W4366583906 cites W4281625362 @default.
• W4366583906 cites W4366583906 @default.
• W4366583906 doi "https://doi.org/10.1002/vms3.1141" @default.
• W4366583906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37079719" @default.
• W4366583906 hasPublicationYear "2023" @default.
• W4366583906 type Work @default.
• W4366583906 citedByCount "1" @default.
• W4366583906 countsByYear W43665839062023 @default.
• W4366583906 crossrefType "journal-article" @default.
• W4366583906 hasAuthorship W4366583906A5005312414 @default.
• W4366583906 hasAuthorship W4366583906A5011138785 @default.
• W4366583906 hasAuthorship W4366583906A5026533666 @default.
• W4366583906 hasAuthorship W4366583906A5034838757 @default.
• W4366583906 hasAuthorship W4366583906A5035014056 @default.
• W4366583906 hasAuthorship W4366583906A5040336064 @default.
• W4366583906 hasAuthorship W4366583906A5041613924 @default.
• W4366583906 hasAuthorship W4366583906A5081043336 @default.
• W4366583906 hasBestOaLocation W43665839061 @default.
• W4366583906 hasConcept C106358424 @default.
• W4366583906 hasConcept C150903083 @default.
• W4366583906 hasConcept C159047783 @default.
• W4366583906 hasConcept C202751555 @default.
• W4366583906 hasConcept C207001950 @default.
• W4366583906 hasConcept C2522874641 @default.
• W4366583906 hasConcept C2777841672 @default.
• W4366583906 hasConcept C2777995582 @default.
• W4366583906 hasConcept C2779690655 @default.
• W4366583906 hasConcept C2780727368 @default.
• W4366583906 hasConcept C54355233 @default.
• W4366583906 hasConcept C55493867 @default.
• W4366583906 hasConcept C81885089 @default.
• W4366583906 hasConcept C86803240 @default.
• W4366583906 hasConceptScore W4366583906C106358424 @default.
• W4366583906 hasConceptScore W4366583906C150903083 @default.
• W4366583906 hasConceptScore W4366583906C159047783 @default.
• W4366583906 hasConceptScore W4366583906C202751555 @default.
• W4366583906 hasConceptScore W4366583906C207001950 @default.
• W4366583906 hasConceptScore W4366583906C2522874641 @default.
• W4366583906 hasConceptScore W4366583906C2777841672 @default.
• W4366583906 hasConceptScore W4366583906C2777995582 @default.
• W4366583906 hasConceptScore W4366583906C2779690655 @default.
• W4366583906 hasConceptScore W4366583906C2780727368 @default.
• W4366583906 hasConceptScore W4366583906C54355233 @default.
• W4366583906 hasConceptScore W4366583906C55493867 @default.
• W4366583906 hasConceptScore W4366583906C81885089 @default.
• W4366583906 hasConceptScore W4366583906C86803240 @default.
• W4366583906 hasFunder F4320321102 @default.
• W4366583906 hasIssue "4" @default.
• W4366583906 hasLocation W43665839061 @default.

• next